Alcon to Acquire U.S. Commercialization Rights to Ophthalmic Eye Drop Simbrinza
Go back to Alcon to Acquire U.S. Commercialization Rights to Ophthalmic Eye Drop Simbrinza| Assisted Living Concepts, Inc. New (NYSE: ALC) | Delayed: 66.86 -2.14 (3.1%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $69.00 | 52 Week High | $14.66 | |||
| Open | $67.78 | 52 Week Low | $6.93 | |||
| Day High | $67.98 | P/E | N/A | |||
| Day Low | $66.85 | EPS | $-1.75 | |||
| Volume | 3,401,145 | |||||
| Assisted Living Concepts, Inc. New (NYSE: ALC) | Delayed: 66.86 -2.14 (3.1%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $69.00 | 52 Week High | $14.66 | |||
| Open | $67.78 | 52 Week Low | $6.93 | |||
| Day High | $67.98 | P/E | N/A | |||
| Day Low | $66.85 | EPS | $-1.75 | |||
| Volume | 3,401,145 | |||||

